Gino K. In is a medical oncologist who specializes in solid tumor and cutaneous oncology. He completed his residency training in hematology and oncology at the University of Southern California Keck School of Medicine, where he was the chief medical oncology fellow. He has stayed on to serve as Assistant Professor of Medicine in the Division of Oncology.
Dr. In’s research focus includes the multi-disciplinary management of melanoma and other skin cancers, with a specific interest in improving cancer outcomes among underserved populations, including adolescents and young adults, and Hispanics. He is actively involved with the USC Adolescent and Young Adult (AYA) Oncology Group, the USC Skin Cancer Task Force, and the Melanoma Prevention Working Group.
Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol. 2017 Aug; 9(8):533-550. View in: PubMed
Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer. Convergent Science Physical Oncology. 2017; 3(3). View in: PubMed
Skin Cancer Prevention Among Hispanics: a Review of the Literature. Epidemiology. 2017. View in: PubMed
Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors: Current Concepts and Controversies. Urol Clin North Am. 2015 Aug; 42(3):347-57. View in: PubMed
Emerging Chemotherapy Agents in Lung Cancer: Nanoparticle Therapeutics for Non-Small Cell Lung Cancer. Transl Cancer Res. 2015; 4(4):340-355. View in: PubMed